Kizzmekia Corbett-Helaire, PhD
BHC 40 Under 40 | Class of 2026 | At the Bench
Melvin J. and Geraldine L. Glimcher Assistant Professor of Immunology and Infectious Diseases | Harvard T.H. Chan School of Public Health | Boston, MA
Dr. Kizzmekia Shanta Corbett-Helaire is one of the scientists whose work helped end a global pandemic.
As scientific lead of the National Institutes of Health Vaccine Research Center coronavirus team, she co-designed mRNA-1273—the COVID-19 vaccine developed with Moderna and the first to enter clinical trials worldwide. The vaccine moved from viral sequencing to Phase 1 trial in just 66 days, an unprecedented timeline that redefined what is possible in vaccine development. It was later shown to be 94.1% effective in Phase 3 trials and has since been deployed globally.
Today, Dr. Corbett-Helaire is the Melvin J. and Geraldine L. Glimcher Assistant Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health, a Shutzer Assistant Professor at the Harvard Radcliffe Institute, and an Associate Member of the Ragon Institute. Her work now centers on pandemic preparedness—developing next-generation vaccines and therapeutic strategies designed not for the last outbreak, but for the ones to come.
The Journey
Dr. Corbett-Helaire’s path into science began early. Raised in Hillsborough, North Carolina, she credits both family and educators with helping shape her trajectory—starting with a third-grade science fair win and a fourth-grade teacher who pushed her into advanced coursework not commonly offered to Black students in her district.
By high school, she was already working in an organic chemistry lab through ProjectSEED, an American Chemical Society initiative aimed at expanding access to research opportunities. She later attended the University of Maryland, Baltimore County as a Meyerhoff Scholar, where she double majored in biological sciences and sociology.
Her early exposure to vaccine research at the NIH Vaccine Research Center—under the mentorship of Dr. Barney Graham—would ultimately come full circle years later, when she returned to help lead one of the most consequential scientific efforts of the 21st century.
The throughline across her journey is clear: a scientist building deep expertise in immunology and virology long before the world fully understood how urgently it would be needed.
### What This Recognition Means
Dr. Corbett-Helaire has received numerous honors recognizing her scientific and public health contributions, but the BHC 40 Under 40 distinction carries a different kind of weight.
Throughout the pandemic and beyond, she has remained deeply committed to community engagement—speaking in churches, community centers, and public forums to demystify vaccine science and address longstanding medical distrust within Black communities.
This recognition reflects that work—where science meets community, and where trust is built not just through innovation, but through presence, communication, and accountability.
What’s Next
At Harvard, the Corbett Lab is focused on advancing pandemic preparedness through a deeper understanding of how the immune system responds to coronavirus spike proteins.
Her research explores vaccine-induced immunity by mapping antibody responses and identifying cross-reactive targets that could inform the development of universal vaccines. The goal is clear: to design interventions that are not reactive, but anticipatory—capable of addressing future threats before they fully emerge.
Beyond the lab, she continues to expand her role as a public-facing science communicator, working to ensure that complex scientific knowledge is accessible, trusted, and actionable—particularly in underserved communities.
“The work that you do is always bigger than you.”
Dr. Corbett-Helaire represents a defining force in modern healthcare—where scientific excellence, urgency, and community impact converge. Her work is not only shaping how we respond to global health crises, but how we prepare for them, ensuring that the future of healthcare is faster, smarter, and more equitable.
Connect
- Instagram: @kizzyphd
- LinkedIn: Kizzmekia S. Corbett-Helaire, PhD
- X: @KizzyPhD
---
The BHC 40 Under 40 Class of 2026 honors the next generation of healthcare leaders reshaping how care is built, delivered, and experienced. Honorees will be celebrated at the Black Health Ball on June 27, 2026.
Editor’s note: This profile was prepared from publicly available sources, including institutional biographies and public remarks. The pull quote is attributed; all other content is editorial synthesis.